417 514

Cited 0 times in

우리나라 말기 신부전 환자의 신장이식과 신장혈액투석과의 비용-효용 분석

Other Titles
 A Renal Transplantation and Hemodialysis Cost-Utility Analysis in Patients with End-Stage Renal Disease 
 김순일  ;  김유선  ;  이후연  ;  함명일  ;  손선영  ;  전경옥  ;  박은철  ;  김명수 
 Journal of the Korean Society for Transplantation, Vol.24(3) : 173-181, 2010 
Journal Title
 Journal of the Korean Society for Transplantation (대한이식학회지) 
Issue Date
Cost-effectiveness analysis ; Cost-utility analysis ; Renal transplantation ; Hemodialysis ; End-stage renal disease (ESRD)
Background: The purpose of this study was to examine the cost-effectiveness of renal transplantation and hemodialysis among end-stage renal disease patients. Methods: Empirical data on treatment costs were collected from five hospitals in Korea. We used European Renal Association-European Dialysis and Transplant Association registry data for transition probability. Quality adjusted life year (QALY) values were derived from the literature. A Markov model was used for predicting the cost utility of transplantation and hemodialysis over a 10-year period. Results: Renal transplantation was less costly and resulted in a better outcome than hemodialysis. The cost per QALY gained was 19,450 thousand won in transplantation patients, whereas it was 36,514 thousand won per QALY gained in hemodialysis patients. Conclusions: Although the cost of the first year after transplantation was expensive, transplantation was more effective over 2 years and was less costly than hemodialysis. The results suggest that transplantation is more cost-effective than hemodialysis in Korea.
Files in This Item:
T201006185.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Myoung Soo(김명수) ORCID logo https://orcid.org/0000-0002-8975-8381
Kim, Soon Il(김순일) ORCID logo https://orcid.org/0000-0002-0783-7538
Kim, Yu Seun(김유선) ORCID logo https://orcid.org/0000-0002-5105-1567
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.